DOCSLIB.ORG

Regulation of Cell Cycle Progression by Forkhead Transcription Factor FOXO3 Through Its Binding Partner DNA Replication Factor Cdt1

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of Cell Cycle Progression by Forkhead Transcription Factor FOXO3 Through Its Binding Partner DNA Replication Factor Cdt1 Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1 Yiru Zhanga, Yuqian Xinga, Lei Zhanga, Yang Meia, Kazuo Yamamotob, Tak W. Makb,1, and Han Youa,1 aState Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian 361005, China; and bCampbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, University Health Network (UHN), Toronto, Ontario, Canada M5G Contributed by Tak W. Mak, February 24, 2012 (sent for review December 21, 2011) To ensure genome stability, DNA must be replicated once and only Cells expressing the constitutively active form of FOXO3 in the S once during each cell cycle. Cdt1 is tightly regulated to make sure phase display a delay in their progression through the G2 phase that cells do not rereplicate their DNA. Multiple regulatory of the cell cycle. Two targets were identified that may mediate mechanisms operate to ensure degradation of Cdt1 in S phase. the effect of FOXOs at the G2/M boundary: cyclin G2 and However, little is known about the positive regulators of Cdt1 GADD45. Thus, FOXO factors mediate cell cycle arrest at the under physiological conditions. Here we identify FOXO3 as G1/S and G2/M transitions, two checkpoints that are critical in a binding partner of Cdt1. FOXO3 forms a protein complex with the cellular response to stress. Notably, these previous reports Cdt1, which in turn blocks its interaction with DDB1 and PCNA. characterizing the biological functions of FOXO in cell cycle Conversely, FOXO3 depletion facilitated the proteolysis of Cdt1 regulation were largely, if not all, based on overexpression of in unperturbed cells. Intriguingly, FOXO3 deficiency resulted in constitutively active form of FOXO members. In contrast to impaired S-phase entry and reduced cell proliferation. We provide these previous reports, here we provide evidence that depleting data that FOXO3 knockdown mimics Cdt1 down-regulation and FOXO3 reduced G1/S transition and cell proliferation. Cdt1 was affects G1/S transitions. Our results demonstrate a unique role identified as a binding partner of FOXO3. FOXO3 is crucial for of FOXO3 in binding to Cdt1 and maintaining its level required maintaining Cdt1 basal levels. Our data suggest a unique bi- CELL BIOLOGY for cell cycle progression. ological function of FOXO3 in cell cycle progression. Results n eukaryotic cells, DNA replication initiates from thousands of Ireplication origins. Each origin acquires replication compe- Cdt1 Interacts with FOXO3. Our laboratory is interested in identi- tence through the assembly of a prereplication complex (pre- fying binding partners of FOXO3. To this end, epitope-tagging fi RC) occurring in late mitosis and early G1 (1–3). Pre-RCs are strategy and af nity chromatography on M2 (anti-Flag antibody) assembled at the origins of DNA replication through the se- agarose beads was used to isolate protein complexes containing quential loading of the initiation factors ORC, Cdc6, Cdt1, and Flag-tagged FOXO3 from nuclear extracts of HEK293T cells. fi MCM2-7 (4). In S phase, pre-RCs are sequentially acted on by After SDS/PAGE fractionation and silver staining, we identi ed ∼ fi two protein kinases, Cdc7 and Cdk2, which promote recruitment a major protein band of 64 kDa that copuri ed with FOXO3 of proteins required for helicase activation and replisome as- and that mass spectrometry revealed to be Cdt1. We next showed fi sembly, leading to origin unwinding and DNA synthesis. To that puri ed recombinant His-FOXO3 was able to interact with A ensure that no replication origin fires more than once, the as- GST-Cdt1 under cell-free conditions (Fig. 1 ), suggesting a di- sembly of the replication apparatus at origins is tightly regulated rect interaction between FOXO3 and Cdt1. To determine the by the cell cycle machinery. Among the most important of these region of Cdt1 required for FOXO3 association, we generated regulatory mechanisms are the degradation of Cdt1 during S a series of Cdt1 deletion mutants. Mutants lacking the Cdt1 N- – terminal domain [amino acids (aa) 1–282] failed to bind to His- phase and the sequestration of Cdt1 by the geminin protein (5 – 7). Phosphorylation of Cdt1 by Cdk2 promotes its binding to FOXO3, whereas those lacking aa 1 200 exhibited robust in- – teraction with FOXO3 (Fig. 1B). These data suggest that the SCF-Skp2 E3 ubiquitin ligase (8 10), which results in its degra- – dation in S phase. In addition to the Skp2 pathway, PCNA/ middle region (aa 200 282) of Cdt1 mediates FOXO3-Cdt1 as- DDB1/Cul4-dependent signaling was found to degrade Cdt1 sociation. Reciprocal mapping using Flag-FOXO3 deletion con- – structs pinpointed FOXO3 aa 396–455 as a critical region for during S phase via the interaction of Cdt1 with PCNA (11 15). C Recently, APC/CCdh1 was proposed as a third ubiquitin ligase FOXO3-Cdt1 interaction (Fig. 1 ), prompting us to designate regulating Cdt1 degradation (16). Cdt1 is also targeted for this region as the Cdt1-binding domain (CBD). To assess if other degradation after DNA damage to stop licensing of new origins FOXO factors could bind to Cdt1, HEK293T cells were trans- until after DNA repair. Both the SCF-Skp2 complex and the fected with vectors overexpressing Flag-tagged FOXO1, FOXO3, or FOXO4. A Flag-tagged mutant lacking FOXO3 aa 395–455 Cul4-DDB1 complex have been reported to induce degradation Δ of Cdt1 after UV irradiation (17, 18). (FOXO3 CBD) served as a negative control for immunopreci- FOXO transcription factors are critical for the regulation of pitations. Surprisingly, only FOXO3 was able to bring down and cell cycle arrest, cell death, and DNA damage repair. Ample evidence has suggested that FOXO exerts a negative effect on cell cycle progression. In dividing cells, overexpression of the Author contributions: Y.Z., Y.X., and H.Y. designed research; Y.Z., Y.X., L.Z., and Y.M. performed research; Y.Z., Y.X., L.Z., Y.M., and K.Y. contributed new reagents/analytic active form of FOXO family members promotes cell cycle arrest tools; Y.Z., Y.X., L.Z., T.W.M., and H.Y. analyzed data; and T.W.M. and H.Y. wrote at the G1/S boundary. Target genes that mediate FOXO-induced the paper. cell cycle arrest are the Cdk inhibitors p27KIP1 and p21 (in the The authors declare no conflict of interest. β presence of TGF- ), the Rb family member p130, and cyclin D1 Freely available online through the PNAS open access option. and D2. The ectopically expressed active form of FOXO factors 1To whom correspondence may be addressed. E-mail: [email protected] or can cause G1 arrest both by up-regulating cell cycle inhibitors [email protected]. (p21 and p27) and by repressing cell cycle activators (cyclin D1/ This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. D2). FOXO factors also regulate other cell cycle checkpoints. 1073/pnas.1203210109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1203210109 PNAS Early Edition | 1of6 Downloaded by guest on September 30, 2021 Interacon A C DBD with Cdt1 Flag-FOXO3(FL) + 1 140-673 + GST Pull His-FOXO3 2 244-673 + Down 3 140-360 - His-FOXO3 4 140-395 - 5 140-455 + GST-Cdt1 6 140-530 + 7 396-455) - Input GST Ni2+ Resin Pull Down Lysate Flag-FOXO3 FL FL 1 2 3 4 5 6 FL FL 1 2 3 4 5 6 His-Cdt1 - + + + + + + + Lysate Pull Down Flag-FOXO3 FL FL 7 FL FL 7 His-Cdt1 - + + GST FOXO3 FOXO3 His His Interacon IP Flag Input B with FOXO3 D Cdt1(FL) + CBD 1 N 52 + 2 N 105 + FOXO1 FOXO4 3 N 140 + Vector FOXO3 FOXO3 CBD FOXO1 FOXO4 Vector FOXO3 FOXO3 4 N 200 + Cdt1 5 N 282 - * 6 C 168 + Flag Ni2+ Resin Pull Down Lysate E Myc-Cdt1 FL FL 1 2 3 4 5 6 FL FL 1 2 3 4 5 6 Myc-Cdt1 Flag-FOXO3 DAPI Merge His-FOXO3 - + + + + + + + Myc His Fig. 1. Cdt1 is a unique FOXO3-interacting protein. (A) Cdt1 directly interacts with FOXO3. Purified FOXO3 was incubated with GST or GST-Cdt1 coupled to GSH-Sepharose. Cell lysates (“Input”) and the eluates (“GST pull down”) were subjected to SDS/PAGE, followed by immunoblot analysis with the indicated antibodies. (B and C) Mapping of the binding domains for FOXO3 and Cdt1. 293T cells were transfected with the indicated constructs, and lysates were incubated with His-FOXO3 (B) or His-Cdt1 (C). Proteins retained on nickel resin were subjected to Western blotting with the indicated antibodies. (D) Cdt1 interacts specifically with FOXO3. 293T cells transfected with indicated plasmids were subjected to immunoprecipitation with M2 beads, followed by im- munoblotting with anti-Cdt1 and anti-Flag antibodies. The asterisk indicates a nonspecific band. (E) Cdt1 and FOXO3 form a complex in the nucleus. MCF-7 cells cotransfected with Myc-Cdt1 and Flag-FOXO3 were subjected to immunofluorescent staining with anti-Myc (red) and anti-Flag (green) antibodies. For A–E, results shown are representative of at least three independent experiments. stabilize endogenous Cdt1, and Cdt1 did not accumulate in cells We also observed decreased Cdt1 protein in the human lung overexpressing FOXO3ΔCBD, FOXO1, or FOXO4 (Fig. 1D). cancer cell line H1299 and in the osteosarcoma cell line U2OS Interestingly, exogenous FOXO3 had no effect on Cdt1 mRNA upon FOXO3 knockdown (Fig. S2B). Importantly, the degree of levels, and geminin protein was unchanged in cells overexpressing reduction in Cdt1 protein was tightly correlated with FOXO3 FOXO proteins (Fig. S1). To determine the subcellular locali- knockdown efficiency, in that MCF-7 cells infected with various zation of the FOXO3-Cdt1 complex, we cotransfected MCF-7 amounts of FOXO3 shRNA lentiviral soup showed dose-de- cells with vectors expressing Myc-Cdt1 and Flag-FOXO3.
Load more

Recommended publications
  • DDB1 Targets Chk1 to the Cul4 E3 Ligase Complex in Normal Cycling Cells and in Cells Experiencing Replication Stress
    Published OnlineFirst March 10, 2009; DOI: 10.1158/0008-5472.CAN-08-3382 Research Article DDB1 Targets Chk1 to the Cul4 E3 Ligase Complex in Normal Cycling Cells and in Cells Experiencing Replication Stress Van Leung-Pineda,1 Jiwon Huh,1 and Helen Piwnica-Worms1,2,3 Departments of 1Cell Biology and Physiology and 2Internal Medicine and 3Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri Abstract protein FANCE (8, 10–12). Chk1 carries out its functions both in the The Chk1 protein kinase preserves genome integrity in normal nucleus and at the centrosome (13). Drugs that block Chk1 kinase proliferating cells and in cells experiencing replicative and activity or enhance its proteolysis by interfering with binding to genotoxic stress. Chk1 is currently being targeted in antican- heat shock protein 90 (HSP90) are currently being tested as cer regimens. Here, we identify damaged DNA-binding protein anticancer agents (14–17). 1 (DDB1) as a novel Chk1-interacting protein. DDB1 is part of Chk1 is regulated by reversible phosphorylation and by an E3 ligase complex that includes the cullin proteins Cul4A ubiquitin-mediated proteolysis. Under periods of replicative stress, and Cul4B. We report that Cul4A/DDB1 negatively regulates the ATRIP/ATR module binds to single-stranded DNA and, Chk1 stability in vivo. Chk1 associates with Cul4A/DDB1 together with Rad17 and the 9-1-1 complex, activates Chk1 in a Claspin-dependent manner (18–22). ATR directly phosphorylates during an unperturbed cell division cycle and both Chk1 317 345 phosphorylation and replication stress enhanced these inter- Chk1 on two COOH-terminal residues: Ser (S317) and Ser actions.
    [Show full text]
  • Geminin Prevents DNA Damage in Vagal Neural Crest Cells to Ensure Normal Enteric Neurogenesis Chrysoula Konstantinidou1,3, Stavros Taraviras2* and Vassilis Pachnis1*
    Konstantinidou et al. BMC Biology (2016) 14:94 DOI 10.1186/s12915-016-0314-x RESEARCH ARTICLE Open Access Geminin prevents DNA damage in vagal neural crest cells to ensure normal enteric neurogenesis Chrysoula Konstantinidou1,3, Stavros Taraviras2* and Vassilis Pachnis1* Abstract Background: In vertebrate organisms, the neural crest (NC) gives rise to multipotential and highly migratory progenitors which are distributed throughout the embryo and generate, among other structures, the peripheral nervous system, including the intrinsic neuroglial networks of the gut, i.e. the enteric nervous system (ENS). The majority of enteric neurons and glia originate from vagal NC-derived progenitors which invade the foregut mesenchyme and migrate rostro-caudally to colonise the entire length of the gut. Although the migratory behaviour of NC cells has been studied extensively, it remains unclear how their properties and response to microenvironment change as they navigate through complex cellular terrains to reach their target embryonic sites. Results: Using conditional gene inactivation in mice we demonstrate here that the cell cycle-dependent protein Geminin (Gem) is critical for the survival of ENS progenitors in a stage-dependent manner. Gem deletion in early ENS progenitors (prior to foregut invasion) resulted in cell-autonomous activation of DNA damage response and p53-dependent apoptosis, leading to severe intestinal aganglionosis. In contrast, ablation of Gem shortly after ENS progenitors had invaded the embryonic gut did not result in discernible survival or migratory deficits. In contrast to other developmental systems, we obtained no evidence for a role of Gem in commitment or differentiation of ENS lineages. The stage-dependent resistance of ENS progenitors to mutation-induced genotoxic stress was further supported by the enhanced survival of post gut invasion ENS lineages to γ-irradiation relative to their predecessors.
    [Show full text]
  • Homo-Protacs for the Chemical Knockdown of Cereblon
    Homo-PROTACs for the Chemical Knockdown of Cereblon Stefanie Lindner 60th ASH Annual Meeting and Exposition December 1, 2018 San Diego , CA IMiDs modulate substrate specificity of the CRBN E3 ligase Thalidomide Lenalidomide omalidomide IKZF1 Multiple IKZF3 Myeloma CRBN Proteasomal CK1α del(5q) MDS Neo- E3 ubiquitin ligase degradation substrate SALL4 Teratogenicity Ito et al., 2010, Science Krönke et al., 2014 Science Lu et al., 2014, Science Krönke et al., 2015, Nature Donovan et al., 2018, Elife Matyskiela et al., 2018, Nat Chem Biol. Proteolysis Targeting Chimeras (PROTACs) Bifunctional molecules for degradation of proteins of interest (POI) Thalidomide POI Lenalidomide ligand Pomalidomide linker POI IMiD CRBN PROTAC Sakamoto et. al, 2001, PNAS Schneekloth et. al, 2004, J Am Chem Soc. Lu et al., 2015, Chem Biol Winter et al., 2017, Mol Cell. Proteolysis Targeting Chimeras (PROTACs) Bifunctional molecules for degradation of proteins of interest (POI) POI IMiD CRBN Proteasomal PROTAC degradation Sakamoto et. al, 2001, PNAS Schneekloth et. al, 2004, J Am Chem Soc. Lu et al., 2015, Chem Biol Winter et al., 2017, Mol Cell. Homodimeric pomalidomide-based PROTACs Linker (size X) O O O HN O O NH O O HN NH O N N O Homo-bifunctional molecules O O Chemical Formula: C36H40N6O11 Molecular Weight: 732,75 Pomalidomide Pomalidomide Chemically CRBN Pom Pom CRBN induced CRBN knockdown Proteasomal POI = CRBN degradation Homodimeric pomalidomide-based PROTACs corresponding linker substructures No. of linear CRBN IKZF1 Linker linker atoms degradation degradation
    [Show full text]
  • Association of ORC with Replication Origins 2013
    Journal of Cell Science 112, 2011-2018 (1999) 2011 Printed in Great Britain © The Company of Biologists Limited 1999 JCS0252 Changes in association of the Xenopus origin recognition complex with chromatin on licensing of replication origins Alison Rowles1,*, Shusuke Tada1,2,‡ and J. Julian Blow1,2,‡,§ 1ICRF Clare Hall Laboratories, South Mimms, Potters Bar, Herts EN6 3LD, UK 2CRC Chromosome Replication Research Group, Department of Biochemistry, University of Dundee, Dundee DD1 5EH, Scotland, UK *Present address: Department of Neuroscience, SmithKline Beecham Pharmaceuticals, New Frontiers Science Park North, Harlow, Essex CM19 5AW, UK ‡Present address: CRC Chromosome Replication Research Group, Department of Biochemistry, University of Dundee, Dundee DD1 5EH, Scotland, UK §Author for correspondence Accepted 29 March; published on WWW 26 May 1999 SUMMARY During late mitosis and early G1, a series of proteins are chromatin, as evidenced by its resistance to elution by 200 assembled onto replication origins that results in them mM salt, and this state persisted when XCdc6 was assembled becoming ‘licensed’ for replication in the subsequent S phase. onto the chromatin. As a consequence of origins becoming In Xenopus this first involves the assembly onto chromatin of licensed the association of XOrc1 and XCdc6 with chromatin the Xenopus origin recognition complex XORC, and then was destabilised, and XOrc1 became susceptible to removal XCdc6, and finally the RLF-M component of the replication from chromatin by exposure to either high salt or high Cdk licensing system. In this paper we examine changes in the way levels. At this stage the essential function for XORC and that XORC associates with chromatin in the Xenopus cell- XCdc6 in DNA replication had already been fulfilled.
    [Show full text]
  • The CUL4A Ubiquitin Ligase Is a Potential Therapeutic Target in Skin Cancer and Other Malignancies
    Chinese Journal of Cancer Review The CUL4A ubiquitin ligase is a potential therapeutic target in skin cancer and other malignancies Jeffrey Hannah1 and Peng-Bo Zhou1,2 Abstract Cullin 4A (CUL4A) is an E3 ubiquitin ligase that directly affects DNA repair and cell cycle progression by targeting substrates including damage-specific DNA-binding protein 2 (DDB2), xeroderma pigmentosum complementation group C (XPC), chromatin licensing and DNA replication factor 1 (Cdt1), and p21. Recent work from our laboratory has shown that Cul4a-deficient mice have greatly reduced rates of ultraviolet-induced skin carcinomas. On a cellular level, Cul4a-deficient cells have great capacity for DNA repair and demonstrate a slow rate of proliferation due primarily to increased expression of DDB2 and p21, respectively. This suggests that CUL4A promotes tumorigenesis (as well as accumulation of skin damage and subsequent premature aging) by limiting DNA repair activity and expediting S phase entry. In addition, CUL4A has been found to be up-regulated via gene amplification or overexpression in breast cancers, hepatocellular carcinomas, squamous cell carcinomas, adrenocortical carcinomas, childhood medulloblastomas, and malignant pleural mesotheliomas. Because of its oncogenic activity in skin cancer and up-regulation in other malignancies, CUL4A has arisen as a potential candidate for targeted therapeutic approaches. In this review, we outline the established functions of CUL4A and discuss the E3 ligase’s emergence as a potential driver of tumorigenesis. Key words Ubiquitination, cullins, DNA damage, cell cycle regulation, skin cancer, therapeutic targets For most cellular proteins, stability and degradation are scaffold, and one or multiple substrate-recruiting proteins at the regulated by the ubiquitin-proteosome system in which proteins are N-terminus[1,2].
    [Show full text]
  • Investigation of the Interplay Between SKP2, CDT1 and Geminin in Cancer Cells
    1 Investigation of the interplay between SKP2, CDT1 and Geminin in cancer cells 2 3 Andrea Ballabeni¶*, Raffaella Zamponi§ 4 5 ¶Department of Systems Biology, Harvard Medical School, Boston, MA, USA 6 (Current affiliation: Harvard School of Public Health, Boston, MA, USA) s 7 t n i 8 §Department of Experimental Oncology, European Institute of Oncology, Milan, Italy r P 9 (Current affiliation: Novartis Institutes of Biomedical research, Cambridge, MA, USA) e r 10 P 11 *Corresponding author E-mail: [email protected], [email protected] 12 13 Abstract 14 Geminin has a dual role in the regulation of DNA replication: it inhibits replication factor CDT1 15 activity during the G2 phase of the cell cycle and promotes its accumulation at the G2/M 16 transition. In this way Geminin prevents DNA re-replication during G2 phase and ensures that 17 DNA replication is efficiently executed in the next S phase. CDT1 was shown to associate with 18 SKP2, the substrate recognition factor of the SCF ubiquitin ligase complex. We investigated the 19 interplay between these three proteins in cancer cell lines. We show that Geminin, CDT1 and 20 SKP2 could possibly form a complex and propose the putative regions of CDT1 and Geminin 21 involved in the binding. We also show that, despite the physical interaction, SKP2 depletion does 22 not substantially affect CDT1 and Geminin protein levels. Moreover, we show that while 1 PeerJ PrePrints | http://dx.doi.org/10.7287/peerj.preprints.794v1 | CC-BY 4.0 Open Access | rec: 16 Jan 2015, publ: 16 Jan 2015 1 Geminin and CDT1 levels fluctuate, SKP2 levels, differently than in normal cells, are almost 2 steady during the cell cycle of the tested cancer cells.
    [Show full text]
  • Geminin-Deficient Neural Stem Cells Exhibit Normal Cell Division and Normal Neurogenesis
    Geminin-Deficient Neural Stem Cells Exhibit Normal Cell Division and Normal Neurogenesis Kathryn M. Schultz1,2, Ghazal Banisadr4., Ruben O. Lastra1,2., Tammy McGuire5, John A. Kessler5, Richard J. Miller4, Thomas J. McGarry1,2,3* 1 Feinberg Cardiovascular Research Institute, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America, 2 Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America, 3 Robert H. Lurie Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America, 4 Department of Molecular Pharmacology and Biological Chemistry, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America, 5 Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America Abstract Neural stem cells (NSCs) are the progenitors of neurons and glial cells during both embryonic development and adult life. The unstable regulatory protein Geminin (Gmnn) is thought to maintain neural stem cells in an undifferentiated state while they proliferate. Geminin inhibits neuronal differentiation in cultured cells by antagonizing interactions between the chromatin remodeling protein Brg1 and the neural-specific transcription factors Neurogenin and NeuroD. Geminin is widely expressed in the CNS during throughout embryonic development, and Geminin expression is down-regulated when neuronal precursor cells undergo terminal differentiation. Over-expression of Geminin in gastrula-stage Xenopus embryos can expand the size of the neural plate. The role of Geminin in regulating vertebrate neurogenesis in vivo has not been rigorously examined. To address this question, we created a strain of Nestin-Cre/Gmnnfl/fl mice in which the Geminin gene was specifically deleted from NSCs.
    [Show full text]
  • Geminin Deploys Multiple Mechanisms to Regulate Cdt1 Before Cell Division Thus Ensuring the Proper Execution of DNA Replication
    Geminin deploys multiple mechanisms to regulate Cdt1 before cell division thus ensuring the proper execution of DNA replication Andrea Ballabenia, Raffaella Zamponib, Jodene K. Moorea, Kristian Helinc,d, and Marc W. Kirschnera,1 aDepartment of Systems Biology, Harvard Medical School, Boston, MA 02115; bNovartis Institutes for Biomedical Research, Cambridge, MA 02139; cBiotech Research and Innovation Centre and dCentre for Epigenetics, University of Copenhagen, 2200 Copenhagen, Denmark Contributed by Marc W. Kirschner, June 7, 2013 (sent for review March 4, 2013) Cdc10-dependent transcript 1 (Cdt1) is an essential DNA replication the initiation of S phase and its duration. We show that although protein whose accumulation at the end of the cell cycle promotes Cdt1 protein accumulates in G2 phase, it still turns over very the formation of pre-replicative complexes and replication in the quickly and that to produce high Cdt1 levels when cells exit next cell cycle. Geminin is thought to be involved in licensing rep- mitosis into G1, the accumulation in G2 must overcome degra- lication by promoting the accumulation of Cdt1 in mitosis, because dation. This regulation is a product of Geminin’s positive regu- decreasing the Geminin levels prevents Cdt1 accumulation and lation of Cdt1 protein and RNA in the preceding G2 phase. impairs DNA replication. Geminin is known to inhibit Cdt1 func- Degradation of Cdt1 is not a consequence of DNA damage, be- tion; its depletion during G2 leads to DNA rereplication and check- cause Cdt1 levels decrease upon Geminin depletion even in point activation. Here we show that, despite rapid Cdt1 protein presence of inhibitors of DNA synthesis.
    [Show full text]
  • Quaternary Structure of the Human Cdt1-Geminin Complex Regulates DNA Replication Licensing
    Quaternary structure of the human Cdt1-Geminin complex regulates DNA replication licensing V. De Marcoa,1, P. J. Gillespieb,2,A.Lib,2,3, N. Karantzelisc, E. Christodouloua,1, R. Klompmakerd, S. van Gerwena, A. Fisha, M. V. Petoukhove, M. S. Iliouf,4, Z. Lygerouf, R. H. Medemad, J. J. Blowb,5, D. I. Svergune, S. Taravirasc, and A. Perrakisa,5 aDepartment of Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, The Netherlands; bWellcome Trust Centre for Gene Regulation and Expression, College of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom; Departments of cPharmacology and fBiology, Medical School, University of Patras, 26500 Rio, Patras, Greece; dDepartment of Medical Oncology and Cancer Genomics Center, Laboratory of Experimental Oncology, University Medical Center Utrecht, Universiteitsweg 100, 3584CG Utrecht, The Netherlands; and eEuropean Molecular Biology Laboratory, Hamburg Outstation, Notkestrasse 85, D-22603 Hamburg, Germany Edited by John Kuriyan, University of California, Berkeley, CA, and approved October 2, 2009 (received for review May 14, 2009) All organisms need to ensure that no DNA segments are rerepli- the remainder becomes inactivated and incapable of inhibiting Cdt1 cated in a single cell cycle. Eukaryotes achieve this through a (16–18). The remaining Geminin gets reactivated in the next cell process called origin licensing, which involves tight spatiotemporal cycle, through a mechanism that is not well understood, but is control of the assembly of prereplicative complexes (pre-RCs) onto dependent on the nuclear import of Geminin, which restores its chromatin. Cdt1 is a key component and crucial regulator of pre-RC ability to block Cdt1 (16, 19, 20).
    [Show full text]
  • The Role of the C-Terminus Merlin in Its Tumor Suppressor Function Vinay Mandati
    The role of the C-terminus Merlin in its tumor suppressor function Vinay Mandati To cite this version: Vinay Mandati. The role of the C-terminus Merlin in its tumor suppressor function. Agricultural sciences. Université Paris Sud - Paris XI, 2013. English. NNT : 2013PA112140. tel-01124131 HAL Id: tel-01124131 https://tel.archives-ouvertes.fr/tel-01124131 Submitted on 19 Mar 2015 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 1 TABLE OF CONTENTS Abbreviations ……………………………………………………………………………...... 8 Resume …………………………………………………………………………………… 10 Abstract …………………………………………………………………………………….. 11 1. Introduction ………………………………………………………………………………12 1.1 Neurofibromatoses ……………………………………………………………………….14 1.2 NF2 disease ………………………………………………………………………………15 1.3 The NF2 gene …………………………………………………………………………….17 1.4 Mutational spectrum of NF2 gene ………………………………………………………..18 1.5 NF2 in other cancers ……………………………………………………………………...20 2. ERM proteins and Merlin ……………………………………………………………….21 2.1 ERMs ……………………………………………………………………………………..21 2.1.1 Band 4.1 Proteins and ERMs …………………………………………………………...21 2.1.2 ERMs structure ………………………………………………………………………....23 2.1.3 Sub-cellular localization and tissue distribution of ERMs ……………………………..25 2.1.4 ERM proteins and their binding partners ……………………………………………….25 2.1.5 Assimilation of ERMs into signaling pathways ………………………………………...26 2.1.5. A. ERMs and Ras signaling …………………………………………………...26 2.1.5. B. ERMs in membrane transport ………………………………………………29 2.1.6 ERM functions in metastasis …………………………………………………………...30 2.1.7 Regulation of ERM proteins activity …………………………………………………...31 2.1.7.
    [Show full text]
  • Delineating the Role of Cooperativity in the Design of Potent Protacs for BTK
    Delineating the role of cooperativity in the design of potent PROTACs for BTK Adelajda Zorbaa,b, Chuong Nguyenb, Yingrong Xub, Jeremy Starrb, Kris Borzillerib, James Smithb, Hongyao Zhuc, Kathleen A. Farleyb, WeiDong Dingb, James Schiemerb, Xidong Fengb, Jeanne S. Changb, Daniel P. Uccellob, Jennifer A. Youngb, Carmen N. Garcia-Irrizaryb, Lara Czabaniukb, Brandon Schuffb, Robert Oliverb, Justin Montgomeryb, Matthew M. Haywardb, Jotham Coeb, Jinshan Chenb, Mark Niosid, Suman Luthrae, Jaymin C. Shahe, Ayman El-Kattand, Xiayang Qiub, Graham M. Westb, Mark C. Noeb, Veerabahu Shanmugasundaramb, Adam M. Gilbertb, Matthew F. Brownb, and Matthew F. Calabreseb,1 aInternal Medicine Research Unit, Pfizer Worldwide Research and Development, Cambridge, MA 02139; bDiscovery Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340; cComputational Sciences, Medicinal Sciences, Pfizer Worldwide Research and Development, Groton, CT 06340; dMedicine Design, Pfizer Worldwide Research and Development, Groton, CT 06340; and ePharmaceutical Sciences Small Molecule, Pfizer Worldwide Research and Development, Cambridge, MA 02139 Edited by Vishva M. Dixit, Genentech, San Francisco, CA, and approved June 20, 2018 (received for review March 1, 2018) Proteolysis targeting chimeras (PROTACs) are heterobifunctional cellular compartments and for targets that have Lys residues small molecules that simultaneously bind to a target protein and accessible for ubiquitination. A second selection criterion en route an E3 ligase, thereby leading to ubiquitination and subsequent to efficacious and selective target degradation could be de novo degradation of the target. They present an exciting opportunity to rational design of PROTACs. In a recent report, Gadd et al. (18) modulate proteins in a manner independent of enzymatic or describe an elegant model of PROTAC-facilitated target–ligase signaling activity.
    [Show full text]
  • CUL4B Promotes Replication Licensing by Up-Regulating the CDK2–CDC6 Cascade
    JCB: Article CUL4B promotes replication licensing by up-regulating the CDK2–CDC6 cascade Yongxin Zou,1,2 Jun Mi,1 Wenxing Wang,1 Juanjuan Lu,1 Wei Zhao,1 Zhaojian Liu,1 Huili Hu,1 Yang Yang,1 Xiaoxing Gao,1 Baichun Jiang,1 Changshun Shao,1 and Yaoqin Gong1 1Ministry of Education Key Laboratory of Experimental Teratology and Institute of Molecular Medicine and Genetics, Shandong University School of Medicine, Jinan, Shandong 250012, China 2Section of Biochemistry and Cell Biology, Division of Life Science, and Center for Cancer Research, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China ullin-RING ubiquitin ligases (CRLs) participate in loading of MCM2 to chromatin. The positive regulation of the regulation of diverse cellular processes in­ CDC6 by CUL4B depends on CDK2, which phosphory- C cluding cell cycle progression. Mutations in the lates CDC6, protecting it from APCCDH1-mediated degra- X-linked CUL4B, a member of the cullin family, cause mental dation. Thus, aside being required for cell cycle reentry retardation and other developmental abnormalities in from quiescence, CDK2 also contributes to pre-replication humans. Cells that are deficient in CUL4B are severely complex assembly in G1 phase of cycling cells. Interest- selected against in vivo in heterozygotes. Here we report ingly, the up-regulation of CDK2 by CUL4B is achieved a role of CUL4B in the regulation of replication licensing. via the repression of miR-372 and miR-373, which target Strikingly, CDC6, the licensing factor in replication, was CDK2. Our findings thus establish a CUL4B–CDK2–CDC6 positively regulated by CUL4B and contributed to the cascade in the regulation of DNA replication licensing.
    [Show full text]